GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosolution Co Ltd (XKRX:086820) » Definitions » EV-to-FCF

Biosolution Co (XKRX:086820) EV-to-FCF : -66.51 (As of Apr. 23, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Biosolution Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Biosolution Co's Enterprise Value is ₩233,736 Mil. Biosolution Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-3,514 Mil. Therefore, Biosolution Co's EV-to-FCF for today is -66.51.

The historical rank and industry rank for Biosolution Co's EV-to-FCF or its related term are showing as below:

XKRX:086820' s EV-to-FCF Range Over the Past 10 Years
Min: -491.36   Med: -36.62   Max: 1189.16
Current: -64.46

During the past 12 years, the highest EV-to-FCF of Biosolution Co was 1189.16. The lowest was -491.36. And the median was -36.62.

XKRX:086820's EV-to-FCF is ranked worse than
100% of 448 companies
in the Biotechnology industry
Industry Median: 2.105 vs XKRX:086820: -64.46

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-23), Biosolution Co's stock price is ₩27400.00. Biosolution Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-1487.000. Therefore, Biosolution Co's PE Ratio (TTM) for today is At Loss.


Biosolution Co EV-to-FCF Historical Data

The historical data trend for Biosolution Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosolution Co EV-to-FCF Chart

Biosolution Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -47.72 -205.06 -6.51 153.33 -53.04

Biosolution Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 153.33 -111.41 -86.77 -78.19 -53.04

Competitive Comparison of Biosolution Co's EV-to-FCF

For the Biotechnology subindustry, Biosolution Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosolution Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosolution Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Biosolution Co's EV-to-FCF falls into.


;
;

Biosolution Co EV-to-FCF Calculation

Biosolution Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=233735.926/-3514.132
=-66.51

Biosolution Co's current Enterprise Value is ₩233,736 Mil.
Biosolution Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-3,514 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biosolution Co  (XKRX:086820) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Biosolution Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=27400.00/-1487.000
=At Loss

Biosolution Co's share price for today is ₩27400.00.
Biosolution Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1487.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Biosolution Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Biosolution Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosolution Co Business Description

Traded in Other Exchanges
N/A
Address
Gongneung-Ro 232, Nowon-gu, 5th Floor, Room 519, Seoul Technopark, Seoul, KOR
Biosolution Co Ltd is a Korean company offering Cell-Based Biotechnology. It is engaged in manufacturing and selling cell therapy products, and developing cell therapeutics technology. Its main areas include cell-based therapeutics with their background in somatic and stem cell technology, and the manufacturing, sales, and R&D of human tissue models for screening toxicity and efficacy with tissue engineering technology.

Biosolution Co Headlines

No Headlines